Next-generation sequencing reveals a novel HLA-C allele, HLA-C*15:255
Mirzokhid Rakhmanov1, Martin Bernheiden1, Murielle Verboom2
1Institute for Transfusion Medicine and Gene Therapy, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
HLA
|March 23, 2023
Summary
A novel Human Leukocyte Antigen C (HLA-C) allele, HLA-C*15:255, was identified. It differs from a known allele, HLA-C*15:02:01, by five specific nucleotide substitutions in key gene regions.
Area of Science:
- Immunogenetics
- Molecular biology
Background:
- Human Leukocyte Antigen (HLA) genes are crucial for immune response.
- Allelic variations within HLA genes can impact immune function and disease susceptibility.
Purpose of the Study:
- To characterize a newly identified HLA-C allele, designated HLA-C*15:255.
- To detail the genetic differences between HLA-C*15:255 and a related known allele.
Main Methods:
- Nucleotide sequencing of the HLA-C gene.
- Comparative analysis of DNA sequences.
Main Results:
- The novel allele HLA-C*15:255 was identified.
- Five distinct nucleotide substitutions differentiate HLA-C*15:255 from HLA-C*15:02:01.
- These substitutions are located within exons 4 and 5 of the HLA-C gene.
Conclusions:
- The identification of HLA-C*15:255 expands the known HLA-C allele repertoire.
- Understanding these specific genetic variations is important for high-resolution HLA typing and immunological studies.
More Related Videos
Related Concept Videos
Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...


